Aster DM Quality Care (NSE:ASTERDM) 3-Year RORE % : 4.57% (As of Mar. 2026)


NSE:ASTERDM Aster DM Quality Care Ltd NSE:ASTERDM
80 GF Score
Price ₹791.55
GF Value ₹660.21
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Aster DM Quality Care 3-Year RORE %?

Aster DM Quality Care NSE:ASTERDM -0.21% 80 3-Year RORE % is 4.57 as of Mar. 2026. GuruFocus rates NSE:ASTERDM with a GF Score™ of 80/100 and a GF Value™ of ₹660.21 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Aster DM Quality Care ranks better than 54.55% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Aster DM Quality Care's 3-Year RORE % for the quarter that ended in Mar. 2026 was 4.57%.

The industry rank for Aster DM Quality Care's 3-Year RORE % or its related term are showing as below:

NSE:ASTERDM's 3-Year RORE % is ranked better than
54.55% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: -0.32 vs NSE:ASTERDM: 4.57

Aster DM Quality Care  (NSE:ASTERDM) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Aster DM Quality Care 3-Year RORE % Related Terms


Aster DM Quality Care 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Aster DM Quality Care's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aster DM Quality Care 3-Year RORE % Chart

Aster DM Quality Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.31 23.94 -36.71 87.89 4.57

Aster DM Quality Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.89 -0.82 0.71 -0.10 4.57

NSE:ASTERDM vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Aster DM Quality Care's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aster DM Quality Care 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Aster DM Quality Care's 3-Year RORE % falls into.


NSE:ASTERDM
80GF Score
Aster DM Quality Care Ltd NSE:ASTERDM
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aster DM Quality Care 3-Year RORE % Calculation

Aster DM Quality Care's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 7.53-2.6 )/( 117.98-10 )
=4.93/107.98
=4.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 4.57 mean?
Aster DM Quality Care (NSE:ASTERDM) has a 3-Year RORE % of 4.57 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Aster DM Quality Care and its competitors. According to the industry distribution chart, Aster DM Quality Care ranks #275 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Aster DM Quality Care's 3-Year RORE % too high?
Aster DM Quality Care's current 3-Year RORE % is 4.57. Based on the distribution chart, Aster DM Quality Care ranks #275 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Aster DM Quality Care has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #275 out of 605 companies for 3-Year RORE %. This puts Aster DM Quality Care in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Aster DM Quality Care and its competitors. Aster DM Quality Care's current 3-Year RORE % is 4.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹660.21, compared to a current price of ₹791.55 — trading 19.9% above its estimated fair value. The current 3-Year RORE % is 4.57. Aster DM Quality Care's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current 3-Year RORE % is 4.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?

Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued. The current stock price of ₹791.55 is trading 19.9% above its estimated GF Value™ of ₹660.21. GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.

Key valuation signals for NSE:ASTERDM:

  • 3-Year RORE %: 4.57
  • GF Value™: ₹660.21 vs. price of ₹791.55 (19.9% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aster DM Quality Care Business Description

Other Exchanges 540975:India
Address 27 and 27/1, Mission Road, Awfis, 2nd Floor, Renaissance Centra, Sampangirama Nagar, Bengaluru, KA, IND, 560027
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
80GF Score

Get the complete analysis for NSE:ASTERDM

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹791.55
Price
₹660.21
GF Value